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Verification of Ventilation before Neuromuscular Blocker Administration during Anesthetic 
Induction and Endotracheal Tube Insertion in the Non-Rapid Sequence Induction Setting
AbstractAnatomically, the upper airway consists of the cartilaginous and bony structures of the nose and mouth, followed by the soft tissue of the oropharynx and laryngopharynx, and ending in the rigid trachea.1 The soft tissue of the pharynx is prone to collapse in the unconscious, or anesthetized, patient and may be further compromised by obe-sity, a large tongue, airway edema, large neck circumference, external compression, and many other factors.1,4 In response to this collapse, anesthesia professionals who plan to place an endotracheal tube have historically been instructed to refrain from administering muscle relaxation until adequate mask ventilation in the anesthetized 
patient was confirmed in order to both avoid a critical hypoxemic event, and to ensure an attempt at an escape wake up.  However, there is little published evidence to support this practice, and the administration of muscle relaxation before ensuring adequate BVM ventilation remains controversial.1-8 
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Introduction
• Anesthesia providers who plan to place an endotracheal tube have 
historically been trained to refrain from administering muscle 
relaxation until adequate mask ventilation in the anesthetized 
patient was confirmed in order to both avoid a critical hypoxemic 
event, and to ensure an attempt at an escape wake up. 
• Mask ventilation is an important skill and can be lifesaving in cases 
of difficult intubation. 
• Just as positioning maneuvers, chin lifts, or airway devices can 
help overcome collapsed pharyngeal tissue, knowing when to 
administer an NMB can make the difference between a failed and 
a successful oxygenation attempt.
• There is little published evidence to support the practice of 
ensuring adequate mask ventilation before NMB adminstration.1-8
Conclusion
• No anesthetic airway plan is assured to work every time, but a 
review of available evidence demonstrates that NMB 
administration is often part of the solution to a difficult BVM 
oxygenation attempt.4,6
• The immediate goal after delivering a non-RSI  anesthetic 
induction should be to optimize oxygenation.4 Optimization of 
oxygenation may include the use of BVM, endotracheal tube or 
laryngeal mask placement; all of which have been demonstrated 
to be made easier by NMB administration.4
• If verification of ventilation before NMB administration was 
essential to patient safety, then all patients needing a rapid 
sequence induction would require an awake fiberoptic intubation.6
• The difficult airway algorithm advises that an airway exam should 
be performed in all patients.13 This alone is one of the best 
indicators of a difficult airway, and along with any history of a 
difficult airway, should serve as the basis for selection of induction 
and airway management technique.
Verification of Ventilation prior to Neuromuscular 
Blocker Administration during Anesthetic Induction
Case Summary
• A 67-year-old, 125 kg, 1.78 m, male presented adequately fasted 
for robotic prostatectomy. 
• The patient’s medical history included prostate cancer, 
hypertension, obesity (with a BMI of 39.5), chronic obstructive 
pulmonary disease (COPD), current smoker with a 28-pack year 
smoking history, obstructive sleep apnea (OSA), diabetes mellitus 
type 2, using a CPAP machine at night with a 2L oxygen (O2) 
bleed in, 2 pillow orthopnea, and dyspnea on exertion with ~ 5 
measure of exercise tolerance (METS). 
• Mallampati class 3, 2 fingers breadth thyromental distance (TMD), 
upper lip bite test Class II, large and short neck, and decreased 
lung sounds. The patient was unable to lay supine and required 2L 
nasal cannula.
• Following anesthetic induction with fentanyl 100 mcg IV, lidocaine 
100 mg IV, and propofol 200 mg IV., the initial bag valve mask 
(BVM) attempt in ramp position was unsuccessful. Oral airway 
insertion, APL adjustment, and two provider BVM ventilation 
resulted in a tidal volume of 100 mL and a SpO2 of 88%.
• Succinylcholine 200 mg was then administered and two provider 
BVM continued. After 30 seconds, the patient’s tidal volume 
increased to 350 mL and the oxygen saturation returned to 98%. 
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Recommendations
• Administering an NMB during induction, with the proper reversal 
agent readily available, should not theoretically alter an escape 
wake up plan.
• While assessing bag mask ventilation prior to administering a 
neuromuscular blocker may provide information relevant to the 
entire perioperative airway management event, additional 
research is needed to further delineate in exactly which situations 
it is most appropriate to assess ventilation versus proceeding 
immediately with neuromuscular blockade.
Paralytics and Suggamadex
•Testing BVM adequacy before NMB administration may aid the 
anesthesia provider in deciding which NMB agent to use for an 
intubation attempt if suggamadex is not readily available.
•Even though no publications exist to support this type of scenario, it 
is possible that NMB administration will not improve BVM attempts 
and create a much more serious situation of cannot intubate cannot 
ventilate. 
•Succinylcholine has a duration of action similar to propofol, of 5-10 
minutes depending on the dose used.10, 14, 16 
• Succinylcholine is metabolized by pseudocholinesterase, and it 
is estimated that an atypical pseudocholinesterase phenotype 
may occur as often as 1 in 480 (heterozygous phenotype) to 1 
in 3,200 (homozygous phenotype) people.15
• An unknown atypical phenotype may result in a can’t intubate 
can’t ventilate (CICV) scenario in a patient who does not have 
the ability to recover from the paralytic before a hypoxic event 
occurs. 
•Suggamadex 16 mg/kg reliably reverses the paralytic effect of a 1.2 
mg/kg dose of rocuronium in about 4.5 minutes, faster than the 
typical offset of the neuromuscular blocking effects of a standard 
dose of succinylcholine.16
• While Suggamadex will rapidly and reliably reverse the effects 
or rocuronium or vecuronium, the choice and timing of 
anesthetic induction agent may preclude return of adequate 
spontaneous ventilation.16
• Neuromuscular reversal in the setting of a collapsed airway may 
result in negative pressure pulmonary edema, and worsen 
patient outcomes.16
Difficult Airway Algorithm
•The algorithm does not address the timing of NMB administration. 
•In a case of difficult BVM, excessive BVM ventilation attempts, 
which may occur while following the difficult airway algorithm, may 
waste valuable functional residual capacity (FRC) or result in 
increased intragastric pressure predisposing the patient to an 
aspiration event. 
• Early NMB administration has potential to prevent increases in 
intragastric pressure and may preserve FRC for an intubation 
attempt.
•Incidence of laryngospasm is 0.78-5%. 17
• Administering an NMB medication from the start of induction 
would rule out a potential laryngospasm and may allow faster 
diagnoses of other airway complications in a more timely 
manner.
Professional Opinion
•When given an emergency scenario of a difficult BVM attempt, 89% 
of survey respondents reported that they would administer a NMB in 
order to improve ventilation efforts.3
• Anesthesia professionals who verify ventilation before 
administering a NMB are establishing relevant, but not 
instrumental, anesthetic induction information.3
• Use of this relevant, but not instrumental, information may have 
benefit postoperatively. 
• May provide evidence of the support needed after a deep 
extubation, or during recovery in the post anesthesia care 
unit.
• However, post intubation laryngeal edema may occur in up to 
30% of patients, resulting in a postsurgical airway that is 
different from the presurgical airway.12
•National audit Project of the Royal College of Aneasthetists and the 
Difficult Airway Society:
• “Where facemask or laryngeal mask anaesthesia is complicated 
by failed ventilation and increasing hypoxia the anaesthetist 
should consider early administration of further anaesthetic agent 
and/or a muscle relaxant to exclude and treat 
laryngospasm…..no anaesthetist should allow airway obstruction 
and hypoxia to develop to the stage where an emergency 
surgical airway is necessary without having administered a 
muscle relaxant.” 9
Controlled Trial
•Ventilation was performed 30 seconds after the patient became 
nonresponsive to eyelash stimulation.5 A non-blinded anesthesia 
professional then administered either rocuronium 0.6 mg/kg or 0.9% 
saline, and repeat ventilation was performed 2 minutes later.5
• BVM ventilation scores were significantly better in the group that 
received rocuronium.5
• Amongst patients who had initially difficult BVM ventilation 
scores, the improvement in BVM ventilation was even more 
pronounced.5
Propofol 
•Anesthetic induction dose of propofol will have respiratory 
depression effects that last 8-11 minutes.10, 16
• Adequate preoxygenation in patients of normal weight resulted 
in a < 90% SpO2 desaturation time of 6.06 minutes, and obese 
patients desaturated in 2.72 minutes.11
• As such, the likelihood of returning to adequate spontaneous 
ventilation before a decrease in SpO2, in a patient under the 
influence of an induction dose of propofol, is small.1,4,6
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